ADIM
PRTA icon

Alpha DNA Investment Management’s Prothena Corp PRTA Stock Holding History

Alpha DNA Investment Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,389
Closed -$1.38M – 139
2021
Q3 		$1.38M Buy
+19,389
New +$1.2M 0.94% 70

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alpha DNA Investment Management's PRTA Position: Q4 2021 in Review

Alpha DNA Investment Management sold out of Prothena Corp (PRTA) in Q4 2021, closing a stake of 19,389 shares — an estimated $1.38M sold.

Alpha DNA Investment Management first reported a position in PRTA in Q3 2021 and held it in 1 quarter. The position peaked at $1.38M in Q3 2021. 196 funds tracked by Wall St. Rank hold PRTA as of Q4 2021.

  • Alpha DNA Investment Management reported no remaining Prothena Corp position as of Q4 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 19,389 Prothena Corp shares in Q4 2021, an estimated $1.38M.
  • Alpha DNA Investment Management first reported a position in Prothena Corp in Q3 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Prothena Corp position peaked at $1.38M in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2021.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.